Literature DB >> 18816775

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

Christopher Teshima1, Richard N Fedorak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816775     DOI: 10.1002/ibd.20728

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

1.  Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.

Authors:  Yonghyun Lee; Seongkeun Jeong; Wooseong Kim; Hyunjeong Kim; Jeong-Hyun Yoon; Seong Hoon Jeong; Yunjin Jung
Journal:  Dig Dis Sci       Date:  2012-11-29       Impact factor: 3.199

2.  Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.

Authors:  Silvio Danese; Ailsa Hart; Axel Dignass; Edouard Louis; Geert D'Haens; Iris Dotan; Gerhard Rogler; Laurence D'Agay; Claudio Iannacone; Laurent Peyrin-Biroulet
Journal:  BMJ Open Gastroenterol       Date:  2016-05-17

Review 3.  Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review.

Authors:  Yueying Chen; Jun Shen
Journal:  EClinicalMedicine       Date:  2022-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.